Related Experiment Video
Updated: May 26, 2026

Simultaneous Isolation of High Quality Cardiomyocytes, Endothelial Cells, and Fibroblasts from an Adult Rat Heart
Published on: May 19, 2017
Organelle interplay in cardiovascular diseases: Mechanisms, pathogenesis, and therapeutic perspectives
Han Wu1, Hongtao Diao1, Feng Zhang1
1Department of Pharmacology (The State-Province Key Laboratories of Biomedicine-Pharmaceutics of China, Key Laboratory of Cardiovascular Research, Ministry of Education), College of Pharmacy, Harbin Medical University, Harbin, China.
Insights
Cardiovascular diseases stem from organelle dysfunction within heart cells. Understanding these cellular interactions offers new therapeutic targets for heart disease.
Area of Science:
- Cardiovascular biology
- Cellular organelle interactions
- Cardiac pathology
Background:
- Cardiovascular diseases (CVDs) are a major global health burden, with limited understanding of their pathogenesis.
- The heart comprises diverse cells, including cardiomyocytes, where organelle dysfunction critically impacts cardiac health.
- Inter-organelle communication is vital for cellular homeostasis, and its disruption is implicated in various diseases.
Purpose of the Study:
- To review how organelle interplay within cardiomyocytes is altered in heart diseases.
- To identify underexplored signaling pathways governing organelle communication in CVDs.
- To evaluate potential therapies targeting organelle interactions for improved CVD treatment.
Main Methods:
- Literature review focusing on organelle communication in cardiovascular diseases.
- Analysis of studies detailing cellular and molecular mechanisms of organelle dysfunction in the heart.
- Synthesis of current research on therapeutic strategies aimed at restoring organelle crosstalk.
Main Results:
- Organelle dysfunction and altered communication are key contributors to cardiac pathologies in CVDs.
- Specific signaling pathways regulating organelle crosstalk in the heart remain incompletely understood.
- Emerging therapeutic strategies show promise in modulating organelle interactions for CVD management.
Conclusions:
- Restoring normal organelle interplay in cardiomyocytes presents a promising avenue for novel CVD therapies.
- Further research into signaling pathways governing organelle communication is crucial for clinical translation.
- Addressing gaps in understanding organelle interactions can provide a basis for improved cardiovascular disease outcomes.
Abstract:
Cardiovascular diseases (CVDs) are the leading cause of rising morbidity and mortality among humans worldwide; however, our approach to the pathogenesis, exploration, and management of CVDs still remains limited. As the heart consists of cardiomyocytes, cardiac fibroblasts, endothelial cells, smooth muscle cells, and several types of cells, different types of dysfunction in the interplay between organelles play an important damaging role, resulting in cardiac pathologies. The interplay between cellular organelles is intricate and vital for maintaining cellular homeostasis, as highlighted by multiple diseases linked to the dysfunction of both organelles. Many studies have revealed the potential mechanisms by which organelles communicate with each other and regulate the pathological processes of CVDs together. However, gaps remain in fully understanding the complexity of these interactions and translating these insights into therapeutic approaches. In this review, we summarized how the interplay between cellular organelles in the cardiomyocytes alters in various heart diseases. We find underexplored areas, such as the crucial signaling pathways governing organelle communication, and discuss their implications for disease future progression. Furthermore, we evaluate emerging potential medicines aimed at restoring organelle interactions. Finally, we propose future directions for researching to advance the development of novel medicines and therapies, addressing current gaps and providing a theoretical basis for improved clinical outcomes in CVDs.
Related Concept Videos
Pathophysiology of Cardiac Performance
Pathophysiology of Heart Failure
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...

